AVTE
Aerovate Therapeutics Inc
$21.2
Earnings Summary
Revenue | $0Mn |
Net Profits | $-20.41Mn |
Net Profit Margins | -Inf% |
Highlights
Aerovate Therapeutics Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q4 2023. On a quarterly growth basis, Aerovate Therapeutics Inc has generated NaN% jump in its revenue since last 3-months.
Aerovate Therapeutics Inc’s net profit fell -35.89% since last year same period to $-20.41Mn in the Q4 2023. On a quarterly growth basis, Aerovate Therapeutics Inc has generated -4.34% fall in its net profits since last 3-months.
Aerovate Therapeutics Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q4 2023. On a quarterly growth basis, Aerovate Therapeutics Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Aerovate Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.76 |
EPS Estimate Current Year | -0.76 |
Highlights
Aerovate Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.76 - a -7.04% fall from last quarter’s estimates.
Aerovate Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.76.
Key Ratios
Key ratios of the Aerovate Therapeutics Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -0.74 |
Highlights
Aerovate Therapeutics Inc’s earning per share (EPS) fell -21.31% since last year same period to -0.74 in the Q4 2023. This indicates that the Aerovate Therapeutics Inc has generated -21.31% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-11-13 | -0.69 | -0.71 | -2.9% |
2023-08-14 | -0.7 | -0.76 | -8.57% |
2024-03-25 | -0.71 | -0.74 | -4.23% |
2023-05-15 | -0.6 | -0.67 | -11.67% |
₹0 US Stocks a/c Opening Fee